Broncus completes debt financing, plans new $30 million round

When we last talked about Broncus Technologies, it was pulling its initial public offering plans and instead trying to line up venture debt financing. It’s done that now, completing a $10 million debt financing ahead of planned $30 million for a Series G round, according to VentureWire.

The Mountain View, Calif.-based Broncus is developing a minimally invasive treatment for emphysema. It has raised over $80 million in its previous four rounds.

Next Story: EBR Systems gets $35 million for new style pacemaker
Previous Story: Healthcare analytics company MedeFinance raises $50M